Skip to Content
Merck
All Photos(1)

Documents

Safety Information

49963

Sigma-Aldrich

β-tri-Calcium phosphate

puriss. p.a., ≥98% β-phase basis (sintered Powder)

Synonym(s):

β-TCP, β-Tricalcium phosphate

Sign Into View Organizational & Contract Pricing
All Photos(1)

About This Item

Empirical Formula (Hill Notation):
Ca3O8P2
CAS Number:
7758-87-4
Molecular Weight:
310.18
EC Number:
231-840-8
MDL number:
MFCD00015984
UNSPSC Code:
12352302
PubChem Substance ID:
329757549
NACRES:
NA.55

grade

puriss. p.a.

Assay

≥98% β-phase basis (sintered Powder)

form

powder

impurities

≤50 mg/kg total heavy metals as lead
≤500 mg/kg total sulfur as SO4 (ICP)

anion traces

chloride (Cl-): ≤50 mg/kg

cation traces

As: ≤0.5 mg/kg
Ba: ≤20 mg/kg
Cd: ≤1 mg/kg
Co: ≤1 mg/kg
Cr: ≤10 mg/kg
Cu: ≤5 mg/kg
Hg: ≤0.5 mg/kg
Ni: ≤5 mg/kg
Pb: ≤5 mg/kg
Zn: ≤20 mg/kg

InChI

1S/3Ca.2H3O4P/c;;;2*1-5(2,3)4/h;;;2*(H3,1,2,3,4)/q3*+2;;/p-6

InChI key

QORWJWZARLRLPR-UHFFFAOYSA-H

Looking for similar products? Visit Product Comparison Guide

Related Categories

Application


  • Tungstosilicic Acid: A Promising Electrolyte for Redox Flow Battery.: This study explores the use of tungstosilicic acid (TSA) as an electrolyte in redox flow batteries (RFB). The research highlights TSA′s high energy density due to its multi-electron transfer capability, making it a promising candidate for enhancing the efficiency and power density of RFBs. This advancement is particularly relevant for large-scale energy storage systems integrating renewable energy technologies (Sharma et al., 2023).

  • Heterogenization of a Tungstosilicic Acid Catalyst for Esterification of Bio-Oil Model Compound.: This paper explores the heterogenization of tungstosilicic acid by supporting it on silica-based materials for the esterification of bio-oil model compounds. The catalyst shows high activity and stability, indicating its potential for industrial applications in bio-oil upgrading (Prasertpong et al., 2022).


Analysis Note

Phase Composition (by XRD analysis):
ß-TCP: >98% ; Hydroxylapatite: <1.0% ; a-TCP: <0%; TTCP: 0%
other Ca-P phases as Calcium pyrophosphate <1.0%

Storage Class Code

11 - Combustible Solids

WGK

WGK 1

Flash Point(F)

Not applicable

Flash Point(C)

Not applicable

Regulatory Listings

Regulatory Listings are mainly provided for chemical products. Only limited information can be provided here for non-chemical products. No entry means none of the components are listed. It is the user’s obligation to ensure the safe and legal use of the product.

JAN Code

49963-VAR:
49963-BULK:
49963-100G:
49963-10G:

Certificates of Analysis (COA)

Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Simon Storgård Jensen et al.
Clinical oral implants research, 17(3), 237-243 (2006-05-05)
The purpose was to qualitatively and quantitatively compare the bone formation and graft resorption of two different bone substitutes used in both orthopedic and oral surgery, with autogenous bone as a positive control. Three standardized bone defects were prepared in
Crystal structure analysis of β-tricalcium phosphate Ca3(PO4)2 by neutron powder diffraction.
Yashima M, et al.
Journal of Solid State Chemistry, 175(2), 272-277 (2003)
S Yamada et al.
Biomaterials, 18(15), 1037-1041 (1997-08-01)
To study the influence of calcium phosphate ceramic solubility on osteoclastic resorption, neonatal rabbit bone cells were cultured for 2 days on hydroxyapatite (HA), beta-tricalcium phosphate (beta-TCP) and two types of biphasic calcium phosphate (BCP) with HA/beta-TCP ratios of 25/75
Michael D Weiden et al.
PloS one, 9(10), e108476-e108476 (2014-10-02)
While exploring the effects of aerosol IFN-γ treatment in HIV-1/tuberculosis co-infected patients, we observed A to G mutations in HIV-1 envelope sequences derived from bronchoalveolar lavage (BAL) of aerosol IFN-γ-treated patients and induction of adenosine deaminase acting on RNA 1
C Lorenzo et al.
Cancer gene therapy, 22(11), 542-551 (2015-10-10)
Interleukin 12 (IL12) is a heterodimeric proinflammatory cytokine that has shown promise as an anticancer agent. However, despite encouraging results in animal models, clinical trials involving IL12 have been unsuccessful due to toxic side effects associated with its systemic administration
View All Related Papers

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service